A study to test the safety and tolerability of Lu AH69593 in adults that are healthy or have narcolepsy.
Phase 1
Not yet recruiting
- Conditions
- Narcolepsy
- Registration Number
- 2024-511073-29-00
- Lead Sponsor
- H. Lundbeck A/S
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Authorised, recruitment pending
- Sex
- Not specified
- Target Recruitment
- 104
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Not specified
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (2)
Suomen Terveystalo Oy
🇫🇮Helsinki, Finland
Clinical Research Services Turku CRST Oy
🇫🇮Turku, Finland
Suomen Terveystalo Oy🇫🇮Helsinki, FinlandGabriele SvedSite contact+358505362405Gabriele.Sved@terveystalo.com